Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05823766 · ClinicalTrials.gov registry record
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
A clinical trial of Traumatic Brain Injury and Post-traumatic Epilepsy, sponsored by University of Pennsylvania.
- Active
- Registry status
- 300
- Enrollment target
- 9
- Study locations
NCT05823766 is a study of Traumatic Brain Injury and Post-traumatic Epilepsy that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 300 participants, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The trial reports 9 study locations across 6 states.
The verdict
NCT05823766, a study of Traumatic Brain Injury and Post-traumatic Epilepsy, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 9
- Study locations
Study Summary
The overarching goal of this study is to improve understanding of the long-range natural history of TBI and post-traumatic epilepsy (PTE) by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.
Conditions Studied
Interventions
- PROCEDURE Blood Draw
- BEHAVIORAL In-Person Outcome Assessment
- PROCEDURE 3T Magnetic Resonance Imaging (MRI)
- BEHAVIORAL Clinical Visit
- PROCEDURE EEG
Study Locations (9)
Texas
- University of Texas at Austin - Austin
- University of Texas Southwestern - Dallas
- Baylor College of Medicine - Houston
Pennsylvania
- University of Pennsylvania/Penn Presbyterian Medical Center - Philadelphia
- University of Pittsburgh - Pittsburgh
California
- University of California, San Francisco - San Francisco
Massachusetts
- Spaulding Rehabilitation Hospital - Charlestown
Ohio
- University of Cincinnati - Cincinnati
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2027-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05823766
The ClinicalTrials.gov registry entry for NCT05823766 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 5 interventions - of which Blood Draw is the first listed.
NCT05823766 reports 9 study locations spanning 6 distinct geographic areas - top geographies include Texas, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT05823766 about?
NCT05823766 is a clinical study titled "Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)". The overarching goal of this study is to improve understanding of the long-range natural history of TBI and post-traumatic epilepsy (PTE) by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.
What is the current status of trial NCT05823766?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2022-03-01. Estimated completion is 2027-02.
What conditions does trial NCT05823766 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, Post-traumatic Epilepsy.
What interventions are being tested in trial NCT05823766?
The interventions under investigation include: Blood Draw (PROCEDURE), In-Person Outcome Assessment (BEHAVIORAL), 3T Magnetic Resonance Imaging (MRI) (PROCEDURE), Clinical Visit (BEHAVIORAL), EEG (PROCEDURE).
Who is sponsoring clinical trial NCT05823766?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05823766 being conducted?
This trial has 9 study locations across California, Massachusetts, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.